MultiPlan plunges over 20%

MultiPlan (NYSE: MPLN) shares went down over 20% before ending at to $7.01 on Wednesday. This dive comes after Muddy Waters Research releases a short report titled “MultiPlan: Private Equity Necrophilia Meets The Great 2020 Money Grab.”

Andina Acquisition Corp. III and EMMAC Life Sciences Limited Announce Termination of Negotiations

Andina Acquisition Corp. III (NASDAQ: ANDA, ANDAW, and ANDAU) (“Andina”) and EMMAC Life Sciences Limited (“EMMAC”) announce that they have today mutually terminated negotiations regarding the proposed business combination between the parties, pursuant to which EMMAC was expected to become a publicly traded company on the NASDAQ Stock Market.